Stock Events

Stock Events

Esperion Therapeutics (ESPR) Q4 2024 Earnings

7NovConfirmed

Q4 2023

Q2 2024

Q3 2024

Q4 2024

-0.5

-0.22

0.06

0.34

Details

Expected EPS

-0.175272

Actual EPS

-0.15

Surprise EPS

0.03

Surprise Percent

+14.42%

Description

Esperion Therapeutics (ESPR) has reported earnings of -0.15 per share for Q4 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.